TABLE 1.
Serotype | No. of patients | No. of samples fromb: |
|||
---|---|---|---|---|---|
Blood | Sputum | NpA | NpS | ||
1 | 2 | 1 | 2 | 2 | 1 |
2 | 1 | 1 | 1 | 1 | 0 |
3 | 11 | 2 | 4 | 7 | 5 |
4 | 2 | 0 | 1 | 2 | 1 |
6B | 1 | 0 | 1 | 1 | 0 |
7F | 9 | 5 | 1 | 5 | 2 |
9N | 3 | 0 | 1 | 2 | 3 |
9V | 6 | 2 | 3 | 4 | 5 |
11A | 4 | 0 | 2 | 4 | 1 |
12F | 2 | 2 | 0 | 1 | 1 |
14 | 9 | 1 | 4 | 4 | 6 |
18C | 3 | 0 | 0 | 2 | 1 |
19A | 4 | 1 | 2 | 2 | 2 |
19F | 3c | 1 | 1 | 1 | 3 |
22F | 2 | 1 | 2 | 2 | 1 |
23F | 8d | 3 | 5 | 6 | 2 |
Total | 70 | 20 | 30 | 46 | 34 |
CAP, community-acquired pneumonia.
NpA, nasopharyngeal aspirate; NpS, nasopharyngeal swab.
One patient with serotype 19F in blood had serotype 14 in NpS (not included in the table).
One patient with serotype 23F in NpA had serotype 11A in NpS (not included in the table).